Collegium Pharmaceutical Inc

COLL · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

24 USD

Margin of Safety

-49.8 %

Rating

BEOBACHTEN

Collegium Pharmaceutical develops and markets prescription pain medications with abuse-deterrent formulations (Abuse-Deterrent Technology) and generates revenues primarily through the sale of its product portfolios to specialty pharmacies and U.S. retail trade.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.